MedTrace Logo

Establish the Role of Premotor and Motor Cortices in tDCS-facilitated Speech Motor Learning

NCT05804344 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-03-25

No results posted yet for this study

Summary

Groups of unimpaired participants will all receive speech motor training of nonwords, and six tDCS conditions will be compared: anodal tDCS over speech motor regions; cathodal tDCS over speech motor regions; anodal tDCS over left frontal regions; cathodal tDCS over left frontal regions; cathodal stimulation over non-speech motor regions (anodal already collected);and sham tDCS (no stimulation). This will address a basic science question about whether the mechanism underlying speech motor learning requires premotor and motor cortical regions to be stimulated, which has implications for treatment of acquired speech impairment. The primary outcome measure will be the difference in production accuracy and changes in motor acuity (measured with duration) of novel consonant cluster production.

Conditions

  • Healthy

Interventions

DEVICE

Anodal speech motor tDCS

tDCS montage set for Anode: C5; Cathode: Fp2

DEVICE

Cathodal speech motor tDCS

tDCS montage set for Anode: Fp2; Cathode: C5

DEVICE

Anodal IFG tDCS

tDCS montage set for Anode: F3; Cathode: Fp2

DEVICE

Cathodal IFG tDCS

tDCS montage set for Anode: Fp2; Cathode: F3

DEVICE

Sham tDCS

tDCS device set in Sham mode

Sponsors & Collaborators

  • New York University

    lead OTHER

Principal Investigators

  • Adam Buchwald, PhD · New York University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-25
Primary Completion
2025-10-01
Completion
2026-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05804344 on ClinicalTrials.gov